Literature DB >> 21892137

Orientation-specific signalling by thrombopoietin receptor dimers.

Judith Staerk1, Jean-Philippe Defour, Christian Pecquet, Emilie Leroy, Hélène Antoine-Poirel, Ian Brett, Miki Itaya, Steven O Smith, William Vainchenker, Stefan N Constantinescu.   

Abstract

Ligand binding to the thrombopoietin receptor is thought to stabilize an active receptor dimer that regulates megakaryocyte differentiation and platelet formation, as well as haematopoietic stem cell renewal. By fusing a dimeric coiled coil in all seven possible orientations to the thrombopoietin receptor transmembrane (TM)-cytoplasmic domains, we show that specific biological effects and in vivo phenotypes are imparted by distinct dimeric orientations, which can be visualized by cysteine mutagenesis and crosslinking. Using functional assays and computational searches, we identify one orientation that represents the inactive dimeric state and another similar to a physiologically activated receptor. Several other dimeric orientations are identified that induce proliferation and in vivo myeloproliferative and myelodysplastic disorders, indicating the receptor can signal from several dimeric interfaces. The set of dimeric thrombopoietin receptors with different TM orientations may offer new insights into the activation of distinct signalling pathways by a single receptor and suggests that subtle differences in cytokine receptor dimerization provide a new layer of signalling regulation that is relevant for disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892137      PMCID: PMC3230373          DOI: 10.1038/emboj.2011.315

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  63 in total

1.  The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif.

Authors:  S N Constantinescu; L J Huang; H Nam; H F Lodish
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

2.  Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor.

Authors:  K F Kubatzky; W Ruan; R Gurezka; J Cohen; R Ketteler; S S Watowich; D Neumann; D Langosch; U Klingmüller
Journal:  Curr Biol       Date:  2001-01-23       Impact factor: 10.834

3.  Generation of mammalian cells stably expressing multiple genes at predetermined levels.

Authors:  X Liu; S N Constantinescu; Y Sun; J S Bogan; D Hirsch; R A Weinberg; H F Lodish
Journal:  Anal Biochem       Date:  2000-04-10       Impact factor: 3.365

4.  Analysis of Tyr to Phe and fa/fa leptin receptor mutations in the PC12 cell line.

Authors:  S Eyckerman; W Waelput; A Verhee; D Broekaert; J Vandekerckhove; J Tavernier
Journal:  Eur Cytokine Netw       Date:  1999-12       Impact factor: 2.737

5.  A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression.

Authors:  P Storz; H Döppler; J Horn-Müller; B Groner; K Pfizenmaier; G Müller
Journal:  Anal Biochem       Date:  1999-12-01       Impact factor: 3.365

6.  Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes.

Authors:  Y Miyakawa; P Rojnuckarin; T Habib; K Kaushansky
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

7.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor.

Authors:  L Dumoutier; E Van Roost; D Colau; J C Renauld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation.

Authors:  Erin E Matthews; Damien Thévenin; Julia M Rogers; Lisa Gotow; Paul D Lira; Lawrence A Reiter; William H Brissette; Donald M Engelman
Journal:  FASEB J       Date:  2011-03-14       Impact factor: 5.191

Review 9.  The nuclear migration gene NudC and human hematopoiesis.

Authors:  C D Gocke; G H Reaman; C Stine; M Y Zhang; S A Osmani; B A Miller
Journal:  Leuk Lymphoma       Date:  2000-11

10.  MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.

Authors:  Yana Pikman; Benjamin H Lee; Thomas Mercher; Elizabeth McDowell; Benjamin L Ebert; Maricel Gozo; Adam Cuker; Gerlinde Wernig; Sandra Moore; Ilene Galinsky; Daniel J DeAngelo; Jennifer J Clark; Stephanie J Lee; Todd R Golub; Martha Wadleigh; D Gary Gilliland; Ross L Levine
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

View more
  30 in total

1.  Eltrombopag, a potent stimulator of megakaryopoiesis.

Authors:  Hana Raslova; William Vainchenker; Isabelle Plo
Journal:  Haematologica       Date:  2016-12       Impact factor: 9.941

2.  An unusual, activating insertion/deletion MPL mutant in primary myelofibrosis.

Authors:  J-P Defour; Y Hoade; A-M Reuther; A Callaway; D Ward; F Chen; S N Constantinescu; N C P Cross
Journal:  Leukemia       Date:  2017-05-22       Impact factor: 11.528

3.  Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin.

Authors:  T Balligand; Y Achouri; C Pecquet; I Chachoua; H Nivarthi; C Marty; W Vainchenker; I Plo; R Kralovics; S N Constantinescu
Journal:  Leukemia       Date:  2016-02-29       Impact factor: 11.528

4.  Topological control of cytokine receptor signaling induces differential effects in hematopoiesis.

Authors:  Kritika Mohan; George Ueda; Ah Ram Kim; Kevin M Jude; Jorge A Fallas; Yu Guo; Maximillian Hafer; Yi Miao; Robert A Saxton; Jacob Piehler; Vijay G Sankaran; David Baker; K Christopher Garcia
Journal:  Science       Date:  2019-05-23       Impact factor: 47.728

5.  His499 Regulates Dimerization and Prevents Oncogenic Activation by Asparagine Mutations of the Human Thrombopoietin Receptor.

Authors:  Emilie Leroy; Jean-Philippe Defour; Takeshi Sato; Sharmila Dass; Vitalina Gryshkova; Myat M Shwe; Judith Staerk; Stefan N Constantinescu; Steven O Smith
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

6.  Mpl traffics to the cell surface through conventional and unconventional routes.

Authors:  Cédric Cleyrat; Anza Darehshouri; Mara P Steinkamp; Mathias Vilaine; Daniela Boassa; Mark H Ellisman; Sylvie Hermouet; Bridget S Wilson
Journal:  Traffic       Date:  2014-07-18       Impact factor: 6.215

7.  Transmembrane helix orientation influences membrane binding of the intracellular juxtamembrane domain in Neu receptor peptides.

Authors:  Chihiro Matsushita; Hiroko Tamagaki; Yudai Miyazawa; Saburo Aimoto; Steven O Smith; Takeshi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

8.  Tryptophan at the transmembrane-cytosolic junction modulates thrombopoietin receptor dimerization and activation.

Authors:  Jean-Philippe Defour; Miki Itaya; Vitalina Gryshkova; Ian C Brett; Christian Pecquet; Takeshi Sato; Steven O Smith; Stefan N Constantinescu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

9.  Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain.

Authors:  Nanaocha Sharma; Geeta Longjam; Gideon Schreiber
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

10.  Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development.

Authors:  Thomas Balligand; Younes Achouri; Christian Pecquet; Gilles Gaudray; Didier Colau; Eva Hug; Yacine Rahmani; Vincent Stroobant; Isabelle Plo; William Vainchenker; Robert Kralovics; Benoît J Van den Eynde; Jean-Philippe Defour; Stefan N Constantinescu
Journal:  Leukemia       Date:  2019-08-30       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.